Exicure, Inc. (XCUR)
NASDAQ: XCUR · Real-Time Price · USD
11.30
+2.86 (33.89%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Exicure Employees
Exicure had 7 employees as of December 31, 2024. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
$71,429
Profits / Employee
-$1,385,857
Market Cap
71.39M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
XCUR News
- 7 days ago - Exicure, Inc. (Nasdaq: XCUR) Nears Completion of Phase 2 Study of GPC-100 in Multiple Myeloma - Business Wire
- 10 days ago - Exicure, Inc. (Nasdaq: XCUR) Announces Their Next Step in Planning for a New Clinical Trial in Acute Myeloid Leukemia (AML) - Business Wire
- 4 weeks ago - Exicure, Inc. Reports Full Year 2024 Financial Results - Business Wire
- 5 weeks ago - Exicure, Inc. (Nasdaq: XCUR) Announces Issuance of New Patent in Australia - Business Wire
- 3 months ago - CORRECTING and REPLACING Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc. - Business Wire
- 3 months ago - Exicure, Inc. Announces Purchase Agreement with GPCR Therapeutics Inc. - Business Wire
- 4 months ago - Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech - Business Wire
- 4 months ago - CORRECTING and REPLACING Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes - Business Wire